NovoCure Competitors and Similar CompaniesClear all

NovoCure's competitors and similar companies include Lyell and Zymeworks.

	NovoCure NovoCure is a company engaged in the development, manufacture, and commercialization of solutions for the treatment of solid tumors.	Lyell Lyell Immunopharma is a T-cell reprogramming company to cure patients with solid tumors.	Zymeworks Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics.
Founding Date	Founding Date 2000	Founding Date 2018	Founding Date 2003
Type	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech medical devices oncology platform therapy	Tags Healthcare biotech oncology platform therapy	Tags Healthcare biotech oncology therapy
Locations	Locations Saint Helier, JE HQ München, DE Haifa, IL Tokyo, JP Root, CH Malvern, US New York, US see more	Locations South San Francisco, US HQ Bothell, US Seattle, US	Locations Vancouver, CA HQ Seattle, US
Employees	Employees 1,488	Employees 188	Employees 45519% increase
Valuation ($)	Valuation ($) 1.8 b	Valuation ($) 243.3 m	Valuation ($) 973.3 m
Financial
Revenue (est.)	Revenue (est.) $655.4m (FY, 2025)	Revenue (est.) $36k (FY, 2025)	Revenue (est.) $106m (FY, 2025)
Net income	Net income ($136.2m) (FY, 2025)	Net income ($274.4m) (FY, 2025)	Net income ($81.1m) (FY, 2025)